BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 17682796)

  • 1. [The necessity of cost-effectiveness analysis in osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.
    Hiligsmann M; Vanoverberghe M; Neuprez A; Bruyère O; Reginster JY
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):359-66. PubMed ID: 20715911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From effective to economical. The value of good osteoporosis therapy].
    Minne HW; Pfeifer M; Pollähne W
    MMW Fortschr Med; 2002 May; 144(21):30-3. PubMed ID: 12134421
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteoporosis: overview in disease, epidemiology, treatment and health economy.
    Pongchaiyakul C; Songpattanasilp T; Taechakraichana N
    J Med Assoc Thai; 2008 Apr; 91(4):581-94. PubMed ID: 18556872
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years.
    Hiligsmann M; Bruyère O; Reginster JY
    Bone; 2010 Feb; 46(2):440-6. PubMed ID: 19716940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential clinical and economic impact of nonadherence with osteoporosis medications.
    Hiligsmann M; Rabenda V; Gathon HJ; Ethgen O; Reginster JY
    Calcif Tissue Int; 2010 Mar; 86(3):202-10. PubMed ID: 20205345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents.
    Singh S; Sun H; Anis AH
    J Rheumatol; 2004 Aug; 31(8):1607-13. PubMed ID: 15290742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to prevent early postmenopausal fracture risk? Proposition of a strategy].
    Trémollieres F; Pouilles JM; Ribot C
    Gynecol Obstet Fertil; 2009 Jan; 37(1):50-6. PubMed ID: 19110461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strontium ranelate: a look back at its use for osteoporosis.
    Reginster JY; Neuprez A
    Expert Opin Pharmacother; 2010 Dec; 11(17):2915-27. PubMed ID: 21050035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients.
    Hiligsmann M; Rabenda V; Bruyère O; Reginster JY
    Health Policy; 2010 Jul; 96(2):170-7. PubMed ID: 20153543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of different intervention strategies to prevent hip fractures].
    Vestergaard P; Mosekilde L
    Ugeskr Laeger; 1999 Aug; 161(31):4400-5. PubMed ID: 10487105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.
    Palacios S; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2012 Feb; 71(2):194-8. PubMed ID: 22176952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials.
    Borgström F; Jönsson B; Ström O; Kanis JA
    Osteoporos Int; 2006 Dec; 17(12):1781-93. PubMed ID: 17009083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic options in osteoporosis.
    Dominguez LJ; Scalisi R; Barbagallo M
    Acta Biomed; 2010; 81 Suppl 1():55-65. PubMed ID: 20518192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis: strategies for prevention and management.
    Keen R
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of osteoporosis interventions for 'incidental' vertebral fractures.
    Majumdar SR; Lier DA; McAlister FA; Rowe BH; Siminoski K; Hanley DA; Russell AS; Johnson JA
    Am J Med; 2013 Feb; 126(2):169.e9-17. PubMed ID: 23331449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the management of postmenopausal osteoporosis for GPs.
    O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF;
    Aust Fam Physician; 2004 Nov; 33(11):910-9. PubMed ID: 15584331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of osteoporosis: strategies for individualized treatment].
    Weber K; Hoffmann A; Leb G
    Wien Med Wochenschr; 1999; 149(16-17):489-92. PubMed ID: 10627987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.